CIRM awards $4.7 million for vision loss gene therapy
On May 29, 2025, The California Institute for Regenerative Medicine (CIRM), one of the world’s largest institutions dedicated…
Lilly expands pain pipeline with acquisition of SiteOne Therapeutics for $1.0 billion in cash
On Mar. 27, 2025, Eli Lilly and SiteOne Therapeutics, a private biotechnology company developing small molecule inhibitors of…
First human bladder transplant performed at UCLA
On May 18, 2025, a surgical team from the University of California, Los Angeles Health (UCLA Health) announced…
Tough microbes found in NASA cleanrooms hold clues to space survival and biotech
On May 12, 2025, a study by scientists at the NASA Jet Propulsion Laboratory and several institutes across…
USDA Suspends Live Animal Imports Through U.S.-Mexico Border
On May 11, 2025, U.S. Department of Agriculture announced the suspension of live cattle, horse, and bison imports…
Biotechnology | Diagnostics | Disease | FDA | Oncology | Women's Health
FDA Approves Teal Health’s Teal Wand™—The First and Only At-Home Self-Collection Device for Cervical Cancer Screening
On May 9, 2025, Teal Health® announced the Food and Drug Administration’s (FDA) approval of the Teal Wand™,…
Gilead boosts planned U.S. investments by $11 billion amid tariff threat
On May 7, 2025, Gilead Sciences announced $11 billion in new planned investment in the U.S. to add…
Regulus Therapeutics announces Agreement to be Acquired by Novartis for $1.7 Billion
On Apr. 30, 2025, Regulus Therapeutics announced that it has entered into an agreement and plan of merger…
Study uncovers key role of RNA modifications in prostate cancer progression
On Mar. 24, 2025, scientists at the UCLA Health Jonsson Comprehensive Cancer Center and the University of Toronto…
Printable Molecule-Selective Nanoparticles Enable Mass Production of Wearable Biosensors
On Feb. 3, 2025, a team of Caltech engineers announced they have developed a technique for inkjet printing…
Large-scale study of brain volume found genetic links to Parkinson’s disease and ADHD
On Oct. 21, 2024, in one of the largest-ever studies of DNA and brain volume, researchers announced they…
CIRM awarded $26 million to advance clinical research across cancer, heart conditions, and rare diseases
On Jun. 28, 2024, the California Institute for Regenerative Medicine (CIRM), one of the world’s largest institutions dedicated…
Biotechnology | Diagnostics | Infectious Disease | Medicine | Neurology | Non-Profit Research | Oncology | Therapeutics
CIRM awarded $53 million to clinical research in heart failure and cystic fibrosis, supporting 10 translational projects
On May 30, 2024, the California Institute for Regenerative Medicine (CIRM) announced it had awarded $53 million to…
Mandatory masking in schools reduced COVID-19 cases during Delta surge
On Mar. 10, 2022, schools with mandatory masking during the Delta surge had approximately 72% fewer cases of…
The U.S. Department of Defense identified more troops to help administer COVID-19 vaccine
On Mar. 10, 2021, the U.S. Department of Defense (DOD) announced that it had identified additional personnel authorized…
Mateon selected by IBM Watson Health for use of IBM Clinical Development Solution to support clinical COVID-19 vaccine candidates
On Jun. 24, 2020, Oncotelic, a wholly owned subsidiary of Mateon Therapeutics, announced that IBM has granted access…
Texas A&M researchers lead testing of tuberculosis vaccine to fight COVID-19
On Apr. 29, 2020, a team of Texas A&M University researchers asked hundreds of frontline medical workers to…
Nanomix received CE Mark for diagnostic panel that aids in rapid identification of life-threatening infections
On Dec. 4. 2019, Nanomix announced that the company had received CE Mark for its S1 Assay for…
UCSD researchers provided new insights into a key pathway that controls critical cell division mechanisms
On Nov. 20, 2019, University of California San Diego (UCSD) researchers provided new insights into a key pathway…
Amgen and Duke Clinical Research Institute initiated first large-scale registry to evaluate real-world lipid management
On Nov. 15, 2019, Amgen and the Duke Clinical Research Institute announced plans to initiate first large-scale registry…
Researchers at UCSD School of Medicine successfully applied phage therapy in mice to treat alcohol-related liver disease
On Nov. 13, 2019, researchers at University of California San Diego (UCSD) School of Medicine announced that they…
Merck acquired San Diego’s Calporta for up to $576 million
On Nov. 12, 2019, Calporta Therapeutics, one of eight San Diego biotech companies Avalon Ventures created with GlaxoSmithKline,…
Genentech announced FDA approval of antiviral drug Xofluza (Baloxavir Marboxil)
On Oct. 17, 2019, Genentech announced the U.S. Food and Drug Administration (FDA) had approved Xofluza (Baloxavir Marboxil),…
deCODE in Iceland agreed to sequence half of UK Biobank participants, largest ever undertaken
On Sept. 11, 2019, deCODE genetics in Iceland announced an agreement with a consortium of government, charity, researchers…
Amgen acquired worldwide rights to psoriasis drug Otezla (apremilast) For $13.4 Billion
On Aug. 26, 2019, Amgen acquired worldwide rights to Otezlaﾮ (apremilast), the only oral, non-biologic treatment for psoriasis…
Eleventh U.S. CRISPR-Cas9 Patent Awarded to University of California, U Vienna, Charpentier
On Aug. 20, 2019, the eleventh U.S. CRISPR-Cas9 patent was awarded to University of California, the University of…
New CRISPR Lab for Genomic Research at UCSF and UC Berkeley in collaboratation with GlaxoSmithKline
On Jun. 13, 2019, the University of California, San Francisco and University of California, Berkeley collaborated with GlaxoSmithKline…
Genentech drug Polivy (polatuzumab vedotin-piiq) granted accelerated approval by FDA
On Jun. 10, 2019, Genentech drug Polivy (polatuzumab vedotin-piiq) announced the U.S. Food and Drug Administration (FDA) had…
Amgen announced the launch of Amgen Community Oncology Research Collaborators
On May 28, 2019, Amgen, along with leading community oncology networks, announced the launch of Amgen Community Oncology…
Amgen announced FDA approval of EVENITY for the treatment of osteoporosis
On Apr. 9 2019, Amgen announced U.S. Food and Drug Administration (FDA) approval of EVENITY (romosozumab-aqqg) for the…